Full length TrkB potentiates estrogen receptor alpha mediated transcription suggesting convergence of susceptibility pathways in schizophrenia

Molecular and Cellular Neuroscience

Volumn 46, Issue 1, 2011, Pages 67-78

  Wong, Jenny ^a,b,c   Woon, Heng Giap ^a,b   Weickert, Cynthia Shannon ^a,b,c  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

BDNF; Estrogen; Estrogen receptor alpha; Schizophrenia; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; INTRACELLULAR SIGNALING; NERVE CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; SECOND MESSENGER;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; CHROMONES; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTOR, TRKB; RESPONSE ELEMENTS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 78650859913     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.08.007     Document Type: Article

References (52)

1. Ali S., Metzger D., Bornert J.M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 1993, 12:1153-1160.
2. Aoki M., Jiang H., Vogt P.K. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl Acad. Sci. USA 2004, 101:13613-13617.
3. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 1994, 8:1208-1214.
4. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl Acad. Sci. USA 1986, 83:2496-2500.
5. Biffo S., Offenhauser N., Carter B.D., Barde Y.A. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 1995, 121:2461-2470.
6. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15:2174-2183.
7. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001, 276:9817-9824.
8. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26:3279-3290.
9. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 1996, 16:3123-3129.
10. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36:131-137.
11. Grigoriadis S., Seeman M.V. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can. J. Psychiatry 2002, 47:437-442.
12. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 2005, 25:372-383.
13. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494.
14. Klein R., Parada L.F., Coulier F., Barbacid M. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 1989, 8:3701-3709.
15. Klein R., Conway D., Parada L.F., Barbacid M. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 1990, 61:647-656.
16. Klein R., Nanduri V., Jing S.A., Lamballe F., Tapley P., Bryant S., Cordon-Cardo C., Jones K.R., Reichardt L.F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991, 66:395-403.
17. Krivosheya D., Tapia L., Levinson J.N., Huang K., Kang Y., Hines R., Ting A.K., Craig A.M., Mei L., Bamji S.X., El-Husseini A. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J. Biol. Chem. 2008, 283:32944-32956.
18. Kulkarni J., de Castella A., Smith D., Taffe J., Keks N., Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res. 1996, 20:247-252.
19. Kulkarni J., Riedel A., de Castella A.R., Fitzgerald P.B., Rolfe T.J., Taffe J., Burger H. Estrogen - a potential treatment for schizophrenia. Schizophr. Res. 2001, 48:137-144.
20. Kulkarni J., Riedel A., de Castella A.R., Fitzgerald P.B., Rolfe T.J., Taffe J., Burger H. A clinical trial of adjunctive oestrogen treatment in women with schizophrenia. Arch. Womens Ment. Health 2002, 5:99-104.
21. Kulkarni J., de Castella A., Fitzgerald P.B., Gurvich C.T., Bailey M., Bartholomeusz C., Burger H. Estrogen in severe mental illness: a potential new treatment approach. Arch. Gen. Psychiatry 2008, 65:955-960.
22. Kuske B., Naughton C., Moore K., Macleod K.G., Miller W.R., Clarke R., Langdon S.P., Cameron D.A. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. Endocrinol Relat. Cancer 2006, 13:1121-1133.
23. Kyosseva S.V. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:997-1006.
24. Kyosseva S.V., Elbein A.D., Griffin W.S., Mrak R.E., Lyon M., Karson C.N. Mitogen-activated protein kinases in schizophrenia. Biol. Psychiatry 1999, 46:689-696.
25. Lannigan D.A. Estrogen receptor phosphorylation. Steroids 2003, 68:1-9.
26. LoPiccolo J., Blumenthal G.M., Bernstein W.B., Dennis P.A. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist. Update 2008, 11:32-50.
27. Luberg K., Wong J., Bernstein W.B., Timmusk T. Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem 2010, 113:952-964.
28. Martin M.B., Franke T.F., Stoica G.E., Chambon P., Katzenellenbogen B.S., Stoica B.A., McLemore M.S., Olivo S.E., Stoica A. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 2000, 141:4503-4511.
29. Masuhiro Y., Mezaki Y., Sakari M., Takeyama K., Yoshida T., Inoue K., Yanagisawa J., Hanazawa S., O'Malley B.W., Kato S. Splicing potentiation by growth factor signals via estrogen receptor phosphorylation. Proc. Nat. Acad. Sci. USA 2005, 102:8126-8131.
30. McGrath J., Saha S., Chant D., Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 2008, 30:67-76.
31. Miranda R.C., Sohrabji F., Toran-Allerand C.D. Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions. Proc. Nat. Acad. Sci. USA 1993, 90:6439-6443.
32. Monick M.M., Powers L.S., Barrett C.W., Hinde S., Ashare A., Groskreutz D.J., Nyunoya T., Coleman M., Spitz D.R., Hunninghake G.W. Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J. Immunol. 2008, 180:7485-7496.
33. Ninkina N., Adu J., Fischer A., Pinon L.G., Buchman V.L., Davies A.M. Expression and function of TrkB variants in developing sensory neurons. EMBO J. 1996, 15:6385-6393.
34. Pillai A. Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neurosignals 2008, 16:183-193.
35. Pillai A., Mahadik S.P. Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophr. Res. 2008, 100:325-333.
36. Raichle M.E., Gusnard D.A. Appraising the brain's energy budget. Proc. Nat. Acad. Sci. USA 2002, 99:10237-10239.
37. Riecher-Rossler A., Seeman M.V. Oestrogens and schizophrenia-introduction. Arch. Womens Ment. Health 2002, 5:91-92.
38. Seeman M.V. Current outcome in schizophrenia: women vs men. Acta Psychiatr. Scand. 1986, 73:609-617.
39. Seeman M.V. Psychopathology in women and men: focus on female hormones. Am. J. Psychiatry 1997, 154:1641-1647.
40. Singh M., Setalo G., Guan X., Warren M., Toran-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 1999, 19:1179-1188.
41. Snapyan M., Lemasson M., Brill M.S., Blais M., Massouh M., Ninkovic J., Gravel C., Berthod F., Gotz M., Barker P.A., Parent A., Saghatelyan A. Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. J. Neurosci. 2009, 29:4172-4188.
42. Stoilov P., Castren E., Stamm S. Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem. Biophys. Res. Commun. 2002, 290:1054-1065.
43. Sun M., Paciga J.E., Feldman R.I., Yuan Z., Coppola D., Lu Y.Y., Shelley S.A., Nicosia S.V., Cheng J.Q. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res. 2001, 61:5985-5991.
44. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., MacLusky N.J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl Acad. Sci. USA 1992, 89:4668-4672.
45. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2003, 8:592-610.
46. Weickert C.S., Ligons D.L., Romanczyk T., Ungaro G., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2005, 10:637-650.
47. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., Straub R.E., Weinberger D.R., Kleinman J.E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet. 2008, 17:2293-2309.
48. Welshons W.V., Wolf M.F., Murphy C.S., Jordan V.C. Estrogenic activity of phenol red. Mol. Cell. Endocrinol. 1988, 57:169-178.
49. Wong J., Weickert C.S. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J. Biol. Chem. 2009, 284:18824-18832.
50. Yamashita H., Nishio M., Toyama T., Sugiura H., Kondo N., Kobayashi S., Fujii Y., Iwase H. Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer. Endocrinal Relat. Cancer 2008, 15:755-763.
51. Yamashita Y., Hishinuma M., Shimada M. Activation of PKA, p38 MAPK and ERK1/2 by gonadotropins in cumulus cells is critical for induction of EGF-like factor and TACE/ADAM17 gene expression during in vitro maturation of porcine COCs. J. Ovarian Res. 2009, 2:20.
52. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997, 88:405-415.